A small subset of coeliac disease (CD) patients experience persisting or recurring symptoms despite strict adherence to a gluten-free diet (GFD). When other causes of villous atrophy have been excluded, these patients are referred to as refractory celiac disease (RCD) patients. RCD can be divided in two types based on the absence (type 1) or presence (type II) of an, usually clonal, intraepithelial lymphocyte population with aberrant phenotype.
10/21/2013
Update on the Diagnosis and Management of Refractory Coeliac Disease
Recent Posts
- Ice Skating for Change: How One Inspiring Teen is Raising Awareness for Celiac Disease on Ice
- argenx Announces Positive Top-Line Results from Phase 2 Study of Investigational Celiac Disease Treatment
- New Study Quantifies Gluten Cross-Contact Risk in Shared Fryers
- First Tracks Biotherapeutics Announces Positive Top-Line Phase 1 Cohort 1 Results for Investigational Celiac Disease Treatment
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Community Spotlight
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Impact Fund
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Recipes
- Research
- Research News
- Trending Topics
Marilyn's Message
3/18/2025
Read moreA Bold New Look for the Celiac Disease Foundation